Dosimetric characterization of radionuclides for systemic tumor therapy: Influence of particle range, photon emission, and subcellular distribution

Medical Physics

Volumn 33, Issue 9, 2006, Pages 3260-3269

  Uusijärvi, Helena ^a   Bernhardt, Peter ^a   Ericsson, Thomas ^b   Forssell Aronsson, Eva ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

Dosimetry; Radionuclide; Subcellular distribution; Therapy

Indexed keywords

AUGER ELECTRON SPECTROSCOPY; AUGERS; BONE; CYTOLOGY; DOSIMETRY; ELECTRONS; PARTICLE SIZE ANALYSIS; PHOTONS; TUMORS;

ACTIVITY CONCENTRATION; AUGER ELECTRON EMITTERS; DOSIMETRIC PROPERTIES; MONOENERGETIC ELECTRONS; RADIONUCLIDE DISTRIBUTION; SUBCELLULAR DISTRIBUTION; THERAPEUTIC APPLICATION; THERAPY;

RADIOISOTOPES;

RADIOISOTOPE;

ALPHA RADIATION; ARTICLE; CANCER THERAPY; CELLULAR DISTRIBUTION; CYTOPLASM; DOSIMETRY; LOW ENERGY RADIATION; MATHEMATICAL MODEL; PARTICLE RADIATION; PHOTON; PHOTON EMISSION TOMOGRAPHY; POSITRON; PRIORITY JOURNAL; SYSTEMIC THERAPY; TUMOR CELL; TUMOR VOLUME;

EID: 33748288381     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.2229428     Document Type: Article

References (25)

1. M. Bardies and J. F. Chatal, "Absorbed doses for internal radiotherapy from 22 beta-emitting radionuclides: Beta dosimetry of small spheres," Phys. Med. Biol. 39, 961-981 (1994).
2. J. Stepanek, B. Larsson, and R. Weinreich, "Auger-electron spectra of radionuclides for therapy and diagnostics," Acta Oncol. 35, 863-868 (1996).
3. G. L. DeNardo, C. L. Siantar, and S. J. DeNardo, "Radiation dosimetry for radionuclide therapy in a nonmyeloablative strategy," Cancer Biother Radiopharm. 17, 107-118 (2002).
4. P. Bernhardt et al., "Dosimetric comparison of radionuclides for therapy of somatostatin receptor-expressing tumors," Int. J. Radiat. Oncol., Biol., Phys. 51, 514-524 (2001).
5. B. W. Wessels and R. D. Rogus, "Radionuclide selection and model absorbed dose calculations for radiolabeled tumor associated antibodies," Med. Phys. 11, 638-645 (1984).
6. H. Uusijarvi, P. Bernhardt, F. Rösch, H. R. Maecke, and E. Forssell-Aronsson, "Electron- and poistron-emitting radiolanthanides for therapy - Aspects of dosimetry and production," J. Nucl. Med. 47, 807-814 (2006).
7. P. Bernhardt, E. Forssell-Aronsson, L. Jacobsson, and G. Skarnemark, "Low-energy electron emitters for targeted radiotherapy of small tumors," Acta Oncol. 40, 602-608 (2001).
8. G. L. Brownell, W. H. Ellett, and A. R. Reddy, "Absorbed fractions for photon dosimetry," J. Nucl. Med., Suppl. 1, 27-39 (1968).
9. W. H. Ellett and R. Humes, "Absorbed fractions for small volumes containing photon-emitting radioactivity," J. Nucl. Med. 13, 26-32 (1972).
10. M. J. Berger, Improved Point Kernel for Electrons and Beta-Ray Dosimetry (U. S. Atomic Energy Commission, Washington, DC, 1973).
11. ICRU 49, "Stopping power and ranges for protons and alpha particles," International Commission on Radiation Units and Measurements, 15 May 1993, ICRU Report No. 49.
12. S. M. Goddu, D. V. Rao, and R. W. Howell, "Multicellular dosimetry for micrometastases: Dependence of self-dose versus cross-dose to cell nuclei on type and energy of radiation and subcellular distribution of radionuclides," J. Nucl. Med. 35, 521-530 (1994).
13. S. M. Goddu, R. W. Howell, and D. V. Rao, "Cellular dosimetry: Absorbed fractions for monoenergetic electron and alpha particle sources and S-values for radionuclides uniformly distributed in different cell compartments," J. Nucl. Med. 35, 303-316 (1994).
14. 111In-labeled somatostatin analogues in a rat tumor model: Somatostatin receptor status and effects of peptide receptor radionuclide therapy," Eur. J. Nucl. Med. Mol. Imaging 32, 1288-1295 (2005).
15. R. Y. Andres et al., "Radionuclides for therapy: A review," in Radionuclides for Therapy, edited by P. A. Schubiger (Basel, Roche, 1986), pp. 9-20.
16. 134La, an Auger electron and positron-emitting generator for radionuclide therapy," Phys. Med. Biol. 47, 615-629 (2002).
17. M. R. McDevitt et al., "Radioimmunotherapy with alpha-emitting nuclides," Eur. J. Nucl. Med. 25, 1341-1351 (1998).
18. E. Browne and R. Firestone, Table of Radioactive Isotopes (Wiley/Interscience, New York, 1986).
19. W. S. Snyder, H. L. Fisher, Jr., M. R. Ford, and G. G. Warner, "Estimates of absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom," J. Nucl. Med., Suppl. 3, 7-52 (1969).
20. 111In-DOTATATE: Biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumos," Eur. J. Nucl. Med. Mol. Imaging 31, 1257-1262 (2004).
21. R. G. Dale, "Dose-rate effects in targeted radiotherapy," Phys. Med. Biol. 41, 1871-1884 (1996).
22. P. Bernhardt, H. Ahlman, and E. Forssell-Aronsson, "Model of metastatic growth valuable for radionuclide therapy," Med. Phys. 30, 3227-3232 (2003).
23. J. A. O'Donoghue, "Implications of nonuniform tumor doses for radioimmunotherapy," J. Nucl. Med. 40, 1337-1341 (1999).
24. M. Faraggi, I. Gardin, J. L. Stievenart, B. D. Bok, and D. Le Guludec, "Comparison of cellular and conventional dosimetry in assessing self-dose and cross-dose delivered to the cell nucleus by electron emissions of 99mTC, 123I, 111In, 67Ga and 201T1," Eur. J. Nucl. Med. 25, 205-214 (1998).
25. Annals of the ICRP, "Radionuclide transformations, energy and intensity if emissions," ICRP Publ. 38, Sutton, Surrey, International Commission of Radiological Protection, 1983.